{
  "id": "603bb1f9aaf5fcfe",
  "title": "FDA Accepts Filing of Ameluz for Superficial Basal Cell Carcinoma",
  "description": "20260212T190000Z",
  "content": "",
  "source": "curetoday.com",
  "source_url": "https://www.curetoday.com/view/fda-accepts-filing-of-ameluz-for-superficial-basal-cell-carcinoma",
  "published_at": "20260212T190000Z",
  "fetched_at": "2026-02-13T00:31:20.432552+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.curetoday.com/view/fda-accepts-filing-of-ameluz-for-superficial-basal-cell-carcinoma",
    "url_mobile": "",
    "title": "FDA Accepts Filing of Ameluz for Superficial Basal Cell Carcinoma",
    "seendate": "20260212T190000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/curetoday/ff265e41ba270487eb579259517833322f64d071-1280x720.jpg",
    "domain": "curetoday.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}